*By Carlo Versano*
Walmart, the world's largest retailer, reported its strongest growth in a decade in its second-quarter earnings released before the bell Thursday.
"Every part of the set of numbers were incredible," said Sucharita Kodali, a retail analyst at Forrester.
Revenue for the quarter was $128 billion ー about $2 billion more than expected ー and adjusted earnings per share were $1.29 compared with an expected $1.22.
Walmart said same-store sales were up 4.5 percent for the second quarter, helped by strong grocery and apparel segments. The e-commerce slice of Walmart's business was up 40 percent compared with the same quarter last year.
The retail giant acquired Jet.com two years ago in a bid to attract more affluent, urban shoppers, and bolster Walmart's e-commerce strategy. It appears to be working, Kodali said, but Amazon maintains an online advantage. "It's still a work in progress," she said Thursday in an interview with Cheddar.
Walmart seems to be riding strong consumer spending, low unemployment, and wage growth to better-than-expected earnings. Shares of Walmart stock rose about 10 percent Thursday morning after the company's earnings report.
But Kodali said the retail sector may face headwinds from tariffs, higher input costs for raw materials, and rising gas prices. "All of these things are going to adversely affect Walmart," she said.
Walmart is the third major retailer to beat earnings expectations this week, after Home Depot and Macy's.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
